Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Sales: 2013-2025

Historic Return on Sales for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to 0.76%.

  • CorMedix's Return on Sales rose 436.00% to 0.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year increase of 436.00%. This contributed to the annual value of -0.41% for FY2024, which is N/A change from last year.
  • CorMedix's Return on Sales amounted to 0.76% in Q3 2025, which was up 78.83% from 0.43% recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Return on Sales peaked at 0.76% during Q3 2025, and registered a low of -666.67% during Q1 2023.
  • Moreover, its 3-year median value for Return on Sales was -0.11% (2024), whereas its average is -111.55%.
  • As far as peak fluctuations go, CorMedix's Return on Sales soared by 1,343bps in 2021, and later slumped by 38,926bps in 2023.
  • Quarterly analysis of 5 years shows CorMedix's Return on Sales stood at -161.25% in 2021, then plummeted by 28,396bps to -445.22% in 2022, then crashed by 38,926bps to -666.67% in 2023, then reached -0.42% in 2024, then spiked by 436bps to 0.76% in 2025.
  • Its last three reported values are 0.76% in Q3 2025, 0.43% for Q2 2025, and 0.21% during Q1 2025.